WAiSCH Logo
Branchenplattform
Über uns Preise Kontakt
WAiSCH
Branchen So funktioniert WAiSCH
Login
WAiSCH
Login
Firmenprofil erstellen
So funktioniert's
Über uns
Preise
Kontakt
AGB
Impressum
Datenschutz

Branchen der Industrie

Bau & Infrastruktur
Druck & Papier
Elektrotechnik
Energie & Umwelt
Holz
Kunststoff
Metall
Transport & Logistik
Verpackung

Weitere Branchen

Beauty & Gesundheit
Bekleidung & Mode
Bildung & Coaching
Blumen & Garten
Chemie & Pharma
Design & Medien
Entsorgung & Recycling
Facility Management
Ferien & Reisen
Finanzen & Versicherungen
Freizeit & Unterhaltung
Gastronomie
Hotellerie
Immobilien
Informatik & Web
Landwirtschaft
Lebensmittel
Marketing
Maschinenbau
Möbel & Einrichtung
Mobilität
Schmuck & Uhren
Sicherheit
Unternehmensberatung
  1. Luoyang Fudau Biotech Co., Ltd.
  2. News
  3. Cell Factory: Suitable Cell Types and Core Applications

Cell Factory: Suitable Cell Types and Core Applications

News
Kunststoff
Fachwissen
The Cell Factory is a multi-layered modular culture system primarily used for large-scale adherent cell culture. Its multi-layer design (e.g., 1-layer, 2-layer, 10-layer, 40-layer, etc.) significantly increases the available culture surface area while saving space, making it suitable for industrial production or large-scale laboratory needs. Below are the common cell types and application areas fo
  • @Cell Factory 10 Layers TC-treated

    The Cell Factory is a multi-layered modular culture system primarily used for large-scale adherent cell culture. Its multi-layer design (e.g., 1-layer, 2-layer, 10-layer, 40-layer, etc.) significantly increases the available culture surface area while saving space, making it suitable for industrial production or large-scale laboratory needs. Below are the common cell types and application areas for this system.

    I. Suitable Cell Types

    Adherent-Dependent Cells (require a surface for attachment):

    Mammalian Cells:Vaccine Production Cells: Vero cells (rabies, polio vaccines), MRC-5 (human diploid cells for rubella, hepatitis B vaccines), HEK293 (adenoviral vector vaccines/gene therapy).

    Stem Cells: Mesenchymal stem cells (MSCs), induced pluripotent stem cells (iPSCs) for differentiation and expansion.

    Cancer Cell Lines: HEp-2 (laryngeal carcinoma), A549 (lung cancer cells), etc., used in drug screening or research.

    Primary Cells: Human skin fibroblasts, hepatocytes, etc. (require optimized culture conditions).

    Special Applications:Microcarrier Suspension Culture: Certain adherent cells can be adapted to stirred-tank bioreactors using microcarriers (e.g., Cytodex), though Cell Factories are typically used for static adherent culture.

    II. Unsuitable Cell Types

    Suspension Cells: Hybridoma cells (monoclonal antibody production), CHO cells (commonly adapted for suspension culture), etc., are better suited for bioreactors or shake flasks.

    Shear-Sensitive Cells: If the Cell Factory is used in perfusion systems, fluid shear stress must be considered.

    III. Key Application Areas

    Vaccine Production:Viral vaccines: Influenza, rabies, adenoviral vector vaccines (e.g., COVID-19 vaccines).

    Biopharmaceuticals:Recombinant protein production (e.g., clotting factors, antibodies) using adherent cell lines.

    Cell Therapy:Large-scale expansion of CAR-T cell precursors or mesenchymal stem cells (adherent phase required).

    Research Applications:High-volume cell experiments (e.g., metabolic analysis, toxicology testing).

    IV. Advantages and Limitations

    Advantages:

    High surface-area-to-volume ratio, saving incubator space.

    Closed-system design reduces contamination risk and supports automation.

    Limitations:

    Cell harvesting requires enzymatic digestion (e.g., trypsin), and multi-layer processing may complicate workflows.

    Not ideal for suspension cells or dynamic culture requirements.

    The Cell Factory is best suited for large-scale expansion of adherent-dependent cells, particularly in vaccines, gene therapy, and cell therapy. Selection should be based on cell type, scale requirements, and process compatibility. For suspension cells, bioreactors or shake flask systems are recommended alternatives.

    learn more
    CELL-FACTORY
    Diese News wurden am Dienstag, 15. Juli 2025, von der Firma Luoyang Fudau Biotech Co., Ltd. auf WAiSCH publiziert und zuletzt am Mittwoch, 10. September 2025, aktualisiert.
    China
    Hersteller
    Luoyang Fudau Biotech Co., Ltd. - WAiSCH

    Luoyang Fudau Biotech Co., Ltd.

    471000 RM 101, 3RD BUILDING, NO.25, YUWENKAI STREET,

    Lesen Sie auch diese Publikationen

    • News
      Kunststoff
      Unternehmen

      INNOTEQ 2023: Nachhaltige Swissness für die MEM-Industrie

      INNOTEQ 2023: Nachhaltige Swissness für die MEM-Industrie - WAiSCH

      WAISCH Group GmbH

      Publiziert am 10. März 2023
      In diesen Tagen findet in den Hallen der BERNEXPO die INNOTEQ statt. Unser CEO berichtet live vom Branchentreffpunkt der Schweizer MEM-Industrie.
      INNOTEQ 2023: Nachhaltige Swissness für die MEM-Industrie - WAiSCH
    • News
      Kunststoff
      Medien

      Coperion: Ausbau der Partnerschaft mit Brückner

      Coperion: Ausbau der Partnerschaft mit Brückner - WAiSCH

      Kunststoff-Schweiz

      Publiziert am 21. August 2025
      Brückner Maschinenbau, weltweit führender Hersteller von Anlagen für Kunststoff-Streckfolien, beauftragt Coperion erneut mit einem Mengenkontrakt über ZSK Doppelschneckenextruder der Baureihe ZSK Mc¹⁸.
      Coperion: Ausbau der Partnerschaft mit Brückner - WAiSCH
    News der Firma Luoyang Fudau Biotech Co., Ltd.
    WAiSCH
    Wir machen Unternehmen sichtbar
    in Branchen, Suchmaschinen und KI-Systemen
    • Über uns
    • Preise
    • Firmenprofil erstellen
    • Zum Login
    • AGB
    • Impressum
    • Datenschutz
    • Kontakt
    swissmadesoftware
    • © 2026 WAiSCH
    • WAISCH Group GmbH
    • Alle Rechte vorbehalten